Table 1 Clinical and demographic characteristics of patients
From: Integrative analysis of mRNA and miRNA sequencing data for gliomas of various grades
| Â | Astrocytoma G2 (n = 58) | Astrocytoma G3 (n = 128) | Oligodendroglioma G2 (n = 102) | Oligodendroglioma G3 (n = 72) | Glioblastoma G4 (n = 564) |
|---|---|---|---|---|---|
Age, years median (range) | 35.5 (20–66) | 43.5 (21–74) | 43 (17–87) | 51.5 (25–75) | 59 (10–89) |
Sex | |||||
 Male | 33 (57%) | 70 (55%) | 59 (58%) | 41 (57%) | 344 (61%) |
 Female | 25 (43%) | 58 (45%) | 43 (42%) | 31 (43%) | 220 (39%) |
Status | |||||
 Survived | 53 (91) | 93 (73%) | 87 (85%) | 59 (82%) | 136 (24%) |
 Fatal outcome | 5 (9%) | 35 (27%) | 15 (15%) | 13 (18%) | 428 (76%) |
Median OS, days, (range) | 743 (3–4412) | 586.5 (0–6423) | 788 (0–4752) | 650.5 (2–4084) | 372 (3–3881) |